Nonnucleoside reverse transcriptase inhibitors (NNRTIs) for HIV
|Generic Name||Brand Name|
|Generic Name||Brand Name|
|efavirenz, emtricitabine, tenofovir||Atripla|
These medicines may be available in other combinations to treat HIV infection.
How It Works
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are antiretroviral medicines. They prevent the human immunodeficiency virus (HIV) from multiplying. When the amount of virus in the blood is kept at a minimum, the immune system has a chance to recover and grow stronger.
Why It Is Used
The use of three or more antiretroviral medicines (highly active antiretroviral therapy, or HAART) is the usual treatment for HIV infection.
The combination of medicines used for HAART will depend on your health, other conditions you might have (such as hepatitis), and results of testing. Talk to your doctor about the best treatment plan for you.
- Experts currently consider your CD4+ count and presence or absence of symptoms more important than your viral load, when considering treatment.
- If your CD4+ count is below 350 cells per microliter (mcL), you should begin treatment to stabilize and increase your CD4+ cell count.
- If your CD4+ count is more than 350 cells per microliter, treatment may be offered to help keep your immune system healthy and prevent AIDS.
- If treatment is not started, your condition will be monitored with frequent CD4+ cell counts.
- If you have symptoms of HIV or AIDS, doctors recommend starting treatment, whatever your CD4+ count is.
- If you are pregnant, you should be treated to prevent your unborn baby (fetus) from becoming infected with HIV.
- If you also have hepatitis B and are starting treatment for it, you should begin treatment for HIV also.
How Well It Works
When compared with people who are given single- or double-medicine therapy, people who are given triple-medicine therapy (HAART):3
- Have a greater reduction in viral load.
- Have better immune system recovery (measured by increased CD4+ cell counts).
- Are less likely to develop resistance to their medicines.
- Are likely to live longer.
Antiretroviral therapy can also decrease symptoms of HIV infection, such as fever, weakness, and weight loss.
The rate at which antiretrovirals decrease viral loads is affected by:1
- CD4+ cell counts at the beginning of treatment.
- Viral load at the beginning of treatment.
- The dosage of the medicines.
- Whether medicines are taken exactly as prescribed.
- Whether antiretroviral medicines have been taken before.
- Whether opportunistic infections are present.
Side effects of nevirapine may include:
- Liver problems, which can be severe and life-threatening. Regular blood tests may be needed to monitor for liver problems.
- Rash, which can be severe.
Side effects of delavirdine may include:
- Nausea, vomiting, and diarrhea.
Side effects of efavirenz may include:
- Difficulty sleeping (insomnia).
- Drowsiness (sedation).
- Vivid dreams.
Side effects of etravirine may include:
Side effects of any combination medicine can include the side effects of any of the single medicines in the combination.
Side effects usually are not as bad after your body has adjusted to the medicine. Report all side effects to your doctor. He or she may be able to help you reduce side effects by giving you other medicines.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
Resistance to single-medicine NNRTI treatment develops quickly. For this reason, they should be used only in combination with other antiretroviral medicines to treat HIV infection or to prevent or delay the development of resistance.
Efavirenz can be taken once a day, in the evening on an empty stomach.
Efavirenz should not be taken at the same time as voriconazole (Vfend), a medicine that is used to treat serious fungal infections. Before you start a new medicine, talk to your doctor about all of the medicines you are taking.
Factors to consider when choosing a combination of medicines include:
- The ability of the medicines to reduce your viral load.
- The likelihood that you will develop resistance to the medicines. If you have already been treated with a certain antiretroviral medicine, you may already know whether you are resistant to medicines in that class.
- Side effects and your willingness to tolerate them.
- The cost of treatment.
Many people think that antiretroviral medicines always have severe side effects. In fact, only a few people experience severe side effects.
- U.S. Department of Health and Human Services (2008). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available online: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
- Hammer, Scott M, et al. (2008). Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society USA Panel. JAMA, 300 (5): 555–570.
- U.S. Department of Health and Human Services (2007). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Adult and Adolescent Guidelines. Available online: http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1.
Last Updated: April 10, 2009